Incyte Reports 2015 Third-Quarter Financial Results and Updates Shareholders on Key Clinical Programs

Go back to Incyte Reports 2015 Third-Quarter Financial Results and Updates Shareholders on Key Clinical Programs

Incyte (INCY) Misses Q3 EPS by 14c; Boosts FY15 Jakafi Net Revenue Outlook

November 3, 2015 7:06 AM EST

Incyte (NASDAQ: INCY) reported Q3 EPS of ($0.22), $0.14 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $187.7 million versus the consensus estimate of $179.3 million.

The Company has updated its full year 2015 financial guidance, as detailed... More